[HTML][HTML] Resistin: A reappraisal

E Acquarone, F Monacelli, R Borghi, A Nencioni… - Mechanisms of ageing …, 2019 - Elsevier
From a biological point of view, aging can be considered a progressive inability of an
organism to react to stress, maintain homeostasis, and survive unfavourable changes during …

Adiposopathy: is “sick fat” a cardiovascular disease?

HE Bays - Journal of the American College of Cardiology, 2011 - jacc.org
Being overweight or obese is a worldwide epidemic. Adiposity can cause fat mass–related
cardiovascular disease (CVD). Adiposity may also cause adipocyte and adipose tissue …

Ceramides in insulin resistance and lipotoxicity

SA Summers - Progress in lipid research, 2006 - Elsevier
Obesity predisposes individuals to the development of insulin resistance in skeletal muscle
and the liver, and researchers have recently proposed two mechanisms by which excess …

Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity

HE Bays, JM González-Campoy, GA Bray… - Expert review of …, 2008 - Taylor & Francis
When caloric intake exceeds caloric expenditure, the positive caloric balance and storage of
energy in adipose tissue often causes adipocyte hypertrophy and visceral adipose tissue …

Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases

DB Kell - BMC medical genomics, 2009 - Springer
Background The production of peroxide and superoxide is an inevitable consequence of
aerobic metabolism, and while these particular'reactive oxygen species'(ROSs) can exhibit a …

Epicardial fat: properties, function and relationship to obesity

SW Rabkin - Obesity reviews, 2007 - Wiley Online Library
Epicardial fat is a relatively neglected component of the heart. The purpose of this review
was to examine the anatomic and biochemical data on epicardial fat; to examine the …

[PDF][PDF] Adipocytokines novel link between inflammation

T Guzik, D Mangalat, R Korbut - J. Physiol. Pharmacol, 2006 - researchgate.net
Ceretain treatments may lead to significant changes in adipocytokine levels. For example
include beta-2 adrenoreceptor agonists, thiazolidinediones as well as androgens lead to …

[HTML][HTML] Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-κB activation in endothelial cells

SR Kim, YH Bae, SK Bae, KS Choi, KH Yoon… - … et Biophysica Acta (BBA …, 2008 - Elsevier
Visfatin has recently been identified as a novel visceral adipokine which may be involved in
obesity-related vascular disorders. However, it is not known whether visfatin directly …

The molecular inflammatory process in aging

HY Chung, B Sung, KJ Jung, Y Zou… - Antioxidants & redox …, 2006 - liebertpub.com
Emerging pathological evidence indicates that major chronic aging-related diseases such
as atherosclerosis, arthritis, dementia, osteoporosis, and cardiovascular diseases, are …

Resistin competes with lipopolysaccharide for binding to toll‐like receptor 4

A Tarkowski, J Bjersing, A Shestakov… - Journal of cellular …, 2010 - Wiley Online Library
Toll‐like receptors (TLRs) are a family of cellular structures activated by recognition of
pathogen associated molecular sequences. The activation of TLRs triggers a variety of …